OCS-05 +SoC (corticosteroid) IV administration

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
OCS-05 in Patients With Optic NeuritisNCT04762017OculisPhase 2Completed2024-09-16Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.